[1]
Bui, M.N. et al. 2022. SURVEY THE RESULTS OF TARGET CONTROL OF SERUM LDL-c CONCENTRATION IN CHRONIC CORONARY SYNDROME PATIENTS TREATED WITH ROSUVASTATIN 10MG AT CAN THO CARDIOVASCULAR HOSPITAL IN 2021-2022. Cantho Journal of Medicine and Pharmacy. 50 (Aug. 2022), 195–202. DOI:https://doi.org/10.58490/ctump.2022i50.145.